177 related articles for article (PubMed ID: 9521547)
1. NMDA-coupled periaqueductal gray glycine receptors modulate anxioselective drug effects on plus-maze performance.
De Souza MM; Schenberg LC; de Pádua Carobrez A
Behav Brain Res; 1998 Feb; 90(2):157-65. PubMed ID: 9521547
[TBL] [Abstract][Full Text] [Related]
2. Elevated T-maze evaluation of anxiety and memory effects of NMDA/glycine-B site ligands injected into the dorsal periaqueductal gray matter and the superior colliculus of rats.
Santos P; Bittencourt AS; Schenberg LC; Carobrez AP
Neuropharmacology; 2006 Aug; 51(2):203-12. PubMed ID: 16697017
[TBL] [Abstract][Full Text] [Related]
3. Anxiolytic effect of glycine antagonists microinjected into the dorsal periaqueductal grey.
Matheus MG; Nogueira RL; Carobrez AP; Graeff FG; Guimarães FS
Psychopharmacology (Berl); 1994 Jan; 113(3-4):565-9. PubMed ID: 7862877
[TBL] [Abstract][Full Text] [Related]
4. Effects of glycine or (+/-)-3-amino-1-hydroxy-2-pyrrolidone microinjections along the rostrocaudal axis of the dorsal periaqueductal gray matter on rats' performance in the elevated plus-maze task.
Teixeira KV; Carobrez AP
Behav Neurosci; 1999 Feb; 113(1):196-203. PubMed ID: 10197919
[TBL] [Abstract][Full Text] [Related]
5. Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice.
Wiley JL; Cristello AF; Balster RL
Eur J Pharmacol; 1995 Dec; 294(1):101-7. PubMed ID: 8788421
[TBL] [Abstract][Full Text] [Related]
6. D-cycloserine injected into the dorsolateral periaqueductal gray induces anxiolytic-like effects in rats.
Gomes FV; Kakihata AM; Semedo AC; Hott SC; Uliana DL; Guimarães FS; Resstel LB
Behav Brain Res; 2014 Sep; 271():374-9. PubMed ID: 24931794
[TBL] [Abstract][Full Text] [Related]
7. Anxiogenic-like effect of glycine and D-serine microinjected into dorsal periaqueductal gray matter of rats.
Schmitt ML; Coelho W; Lopes-de-Souza AS; Guimarães FS; Carobrez AP
Neurosci Lett; 1995 Apr; 189(2):93-6. PubMed ID: 7609926
[TBL] [Abstract][Full Text] [Related]
8. Anxiogenic-like effects induced by NMDA receptor activation are prevented by inhibition of neuronal nitric oxide synthase in the periaqueductal gray in mice.
Miguel TT; Nunes-de-Souza RL
Brain Res; 2008 Nov; 1240():39-46. PubMed ID: 18793618
[TBL] [Abstract][Full Text] [Related]
9. Opposite effects of substance P fragments C (anxiogenic) and N (anxiolytic) injected into dorsal periaqueductal gray.
De Araújo JE; Huston JP; Brandão ML
Eur J Pharmacol; 2001 Nov; 432(1):43-51. PubMed ID: 11734186
[TBL] [Abstract][Full Text] [Related]
10. Modulation of defensive behavior by periaqueductal gray NMDA/glycine-B receptor.
Carobrez AP; Teixeira KV; Graeff FG
Neurosci Biobehav Rev; 2001 Dec; 25(7-8):697-709. PubMed ID: 11801295
[TBL] [Abstract][Full Text] [Related]
11. Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey.
Guimarães FS; Carobrez AP; De Aguiar JC; Graeff FG
Psychopharmacology (Berl); 1991; 103(1):91-4. PubMed ID: 1672463
[TBL] [Abstract][Full Text] [Related]
12. Interplay between glutamate and serotonin within the dorsal periaqueductal gray modulates anxiety-related behavior of rats exposed to the elevated plus-maze.
Moraes CL; Bertoglio LJ; Carobrez AP
Behav Brain Res; 2008 Dec; 194(2):181-6. PubMed ID: 18675851
[TBL] [Abstract][Full Text] [Related]
13. Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats.
Bertoglio LJ; Carobrez AP
Psychopharmacology (Berl); 2003 Dec; 170(4):335-42. PubMed ID: 13680083
[TBL] [Abstract][Full Text] [Related]
14. Dependency of nociception facilitation or inhibition after periaqueductal gray matter stimulation on the context.
Martins MA; De Castro Bastos L; Melo NE; Tonussi CR
Behav Brain Res; 2010 Dec; 214(2):260-7. PubMed ID: 20561964
[TBL] [Abstract][Full Text] [Related]
15. Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray.
Netto CF; Guimarães FS
Neuropsychopharmacology; 2004 Jan; 29(1):101-7. PubMed ID: 14583742
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of non-NMDA receptors in the dorsal periaqueductal grey induces anxiolytic effect in the elevated plus maze.
Matheus MG; Guimarães FS
Psychopharmacology (Berl); 1997 Jul; 132(1):14-8. PubMed ID: 9272754
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin AT1 receptors modulate the anxiogenic effects of angiotensin (5-8) injected into the rat ventrolateral periaqueductal gray.
Genaro K; Fabris D; Fachim HA; Prado WA
Peptides; 2017 Oct; 96():8-14. PubMed ID: 28851568
[TBL] [Abstract][Full Text] [Related]
18. Anxiolytic-like effects of N-methyl-D-aspartate-associated glycine receptor ligands in the rat potentiated startle test.
Anthony EW; Nevins ME
Eur J Pharmacol; 1993 Dec; 250(2):317-24. PubMed ID: 7906654
[TBL] [Abstract][Full Text] [Related]
19. Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence.
Popik P; Wróbel M; Nowak G
Neuropharmacology; 2000 Sep; 39(12):2278-87. PubMed ID: 10974311
[TBL] [Abstract][Full Text] [Related]
20. Effects of 5,7 dichlorokynurenic acid on conflict, social interaction and plus maze behaviors.
Corbett R; Dunn RW
Neuropharmacology; 1993 May; 32(5):461-6. PubMed ID: 8100622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
